Cell proliferation regulating inhibitor of phosphatase 2A (CIP2A) has been shown to activate Akt signaling via inhibition of Akt dephosphorylation in different types of cancer, including lung cancer [14,15,16,17,18]. Here, AKT1 is linked to lung cancer.